KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAmortization of Deferred ChargesAmortization of GoodwillAmortization of GoodwillCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionDivestmentsDividends Paid - CommonDividends Paid - CommonExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Evolent Health (EVH) Share-based Compensation (2016 - 2026)

Evolent Health has reported Share-based Compensation over the past 11 years, most recently at $2.4 million for Q4 2025.

  • For Q4 2025, Share-based Compensation rose 139.18% year-over-year to $2.4 million; the TTM value through Dec 2025 reached $39.7 million, changed 0.02%, while the annual FY2025 figure was $39.7 million, 0.02% changed from the prior year.
  • Share-based Compensation for Q4 2025 was $2.4 million at Evolent Health, down from $14.7 million in the prior quarter.
  • Over five years, Share-based Compensation peaked at $18.8 million in Q1 2024 and troughed at -$6.1 million in Q4 2024.
  • A 5-year average of $8.5 million and a median of $9.6 million in 2023 define the central range for Share-based Compensation.
  • Biggest five-year swings in Share-based Compensation: soared 195.16% in 2022 and later plummeted 157.67% in 2024.
  • Year by year, Share-based Compensation stood at $5.0 million in 2021, then skyrocketed by 195.16% to $14.6 million in 2022, then fell by 27.53% to $10.6 million in 2023, then plummeted by 157.67% to -$6.1 million in 2024, then skyrocketed by 139.18% to $2.4 million in 2025.
  • Business Quant data shows Share-based Compensation for EVH at $2.4 million in Q4 2025, $14.7 million in Q3 2025, and $11.6 million in Q2 2025.